Philadelphia, April 17, 2008 – Babies with an eye-alignment disorder called infantile esotropia have delays in motor development milestones, but development “catches up” after corrective surgery, reports a study in the April Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus).
Led by James R. Drover, PhD, of the Retina Foundation of Southwest Texas, Dallas, the researchers assessed developmental milestones in 161 infants with infantile esotropia, or crossed eyes. These infants need surgery on the eye muscles to correct the alignment. However, it has been unclear whether surgery to correct esotropia influences other aspects of infant development.
To answer this question, the researchers had parents complete an infant development questionnaire before and/or after corrective surgery. The questionnaire assessed fine-motor skills, such as grasping a toy and handling a bottle (sensorimotor development); as well are large-muscle skills, such as sitting, standing, and walking (gross motor development). A group of children with normal eye alignment were studied for comparison.
Before surgery, infants with esotropia had delays in both milestones. The developmental delays appeared as early as four to five months of age and were still present at ten months.
The sensorimotor delays were “particularly profound,” and probably reflected the importance of normal binocular vision (both eyes working together) in fine-muscle tasks. The delays in gross motor development, while not as severe, were still significant.
In contrast, infants tested after esotropia surgery had no delays in developmental milestones. In fact, they actually had a faster rate of sensorimotor development, suggesting that correcting their binocular vision helped their development to “catch up” to that of normal infants.
Infantile esotropia is one of a group of disorders called strabismus, in which the eyes are not aligned normally. Without surgery to correct the problem, depth perception cannot develop. Because vision develops rapidly between three to eight months of age, infantile esotropia might cause delays in developmental milestones—for example, grasping objects, crawling, or walking—that depend on normal vision. However, previous studies were unclear as to whether early surgery helps normal development, partly because many babies with esotropia are not sent for expert evaluation by a pediatric ophthalmologist until they are over one year old.
The new results show that babies with infantile esotropia have significant delays in developmental milestones before surgery, and, suggests that development catches up to normal after surgery to correct eye alignment. Dr. Drover and colleagues suspect that the rapid rate of development after surgery results from the improvement in binocular function.
“Doctors continue to disagree over when is the best time to correct strabismus in children, because most of the focus has been on when it can best help their vision,” comments Dr. David G. Hunter of Children's Hospital Boston and editor-in-chief of the Journal of AAPOS. “This study says that surgery to correct strabismus doesn't just help the eyes—it helps the whole child.”
Notes to Editors:
The article appears in Journal of AAPOS (April 2008), published by Elsevier on behalf of the American Association for Pediatric Ophthalmology and Strabismus. Full text of the article mentioned above is available upon request. Contact Jayne Dawkins at (215) 239-3674 or email@example.com to obtain a copy or to schedule an interview.
About Journal of AAPOS
Journal of AAPOS presents expert information on children's eye diseases and on strabismus as it impacts all age groups. Major articles by leading experts in the field cover clinical and investigative studies, treatments, case reports, surgical techniques, descriptions of instrumentation, current concept reviews, and new diagnostic techniques. The Journal is the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.